Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2017

Case #3 (With Discussion): Discordance Between FFR and iFR

Presenter: William F. Fearon, Matthias Götberg, Gary S. Mintz, Allen Jeremias

November 01, 2017

Presentation TCT 2017

Next Generation Bio Innovation

Presenter: Andreu M Climent, Amit N. Patel

October 31, 2017

Presentation TCT 2017

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Presenter: Andreu M Climent, Amit N. Patel, Angel Arenal

October 31, 2017

Presentation TCT 2017

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

Presenter: Andreu M Climent, Amit N. Patel, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Presenter: Andreu M Climent, Amit N. Patel, Gary L. Schaer

October 31, 2017

$My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!$

Presentation TCT 2017

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Presenter: Timothy D. Henry, Marc S. Penn

October 31, 2017

Presentation TCT 2017

Critical Limb Ischemia Update, and the STOP-PAD Trial

Presenter: Timothy D. Henry, Marc S. Penn, Mehdi H. Shishehbor

October 31, 2017

Presentation TCT 2017

New Strategies: Repetitive Injections

Presenter: Timothy D. Henry, Marc S. Penn, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

New Trials: REGENT-VSEL

Presenter: Timothy D. Henry, Marc S. Penn, Wojtek Wojakowski

October 31, 2017

Presentation TCT 2017

First of the Class: Tissue Engineering

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Christopher Kelly, MD

October 31, 2017

Presentation TCT 2017

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

In This Case: Doppler-Based CFR Uncovered Discordance With FFR (With Discussion)

Presenter: Justin E. Davies, Nils Johnson, Tim P. van de Hoef

October 30, 2017

Advertisement

Case #3 (With Discussion): Discordance Between FFR and iFR

Next Generation Bio Innovation

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Critical Limb Ischemia Update, and the STOP-PAD Trial

New Strategies: Repetitive Injections

New Trials: REGENT-VSEL

First of the Class: Tissue Engineering

New Strategies for a Chronic Scenario: Combinative Approaches

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

In Which Direction is Cell Based Heart Failure Therapy Headed?

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 75: Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients With Left Main Disease: Results from the EXCEL Trial

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

In This Case: Doppler-Based CFR Uncovered Discordance With FFR (With Discussion)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content